Strelitz Diabetes Research Initiatives
Our search for a cure
The Strelitz Diabetes Center scientific research team is aggressively pursuing diabetes research aimed at greater understanding of the factors that contribute to the disease and its complications. Uncovering and understanding diabetes’ underlying mechanisms allows for new therapies to be designed to combat the development of this disease. We are focused on finding and promoting solutions to diabetes’ myriad complications and turning the tide on diabetes by preventing, reversing and ultimately curing this disease.
In the laboratory, new discoveries produce new understanding; new understanding creates a need for further new discoveries. Each discovery is like an excavation – as one layer is revealed, it leads to digging deeper for other clues to the mysteries of factors essential to enlist therapeutic modalities. Everyday, our team of scientists are working tirelessly to bring us closer to a cure that will heal people’s lives.
In order to succeed in these goals, we have developed a cross-disciplinary approach to our diabetes research initiatives. We have developed close collaborative relationships with anatomists, neuropathologists, geriatricians, neurobiologists, podiatrists, exercise physiologists, physiologists, molecular biologists, immunologists and neurologists.
Through the integration of basic science and clinical research, the Strelitz Diabetes Center conducts numerous clinical trials designed to develop possible new treatments for diabetes and diabetic complications.
A clinical trial is a research study that is designed to test the effectiveness of new medical treatments or other medical interventions. Each study is designed to answer scientific questions and to find better ways to treat individuals with a specific disease.
All clinical trials conducted at the Strelitz Diabetes Center are approved by the FDA and by the EVMS Institutional Review Board (IRB).
The Strelitz Diabetes Center also conducts a variety of investigator-initiated research studies to explore better management strategies and reduce diabetic complications.
Current Clinical Trials
Below is a list of our current clinical trials. For more information, please contact our Diabetes Research Hotline at
(757) 446-7933 or send us an email at email@example.com.
- Acute Coronary Syndrome Clinical Research Study
- Diabetes Clinical Research Study
- Diabetes Clinical Trial
- Gene Therapy for Painful Neuropathy
- Implantable Exenatide (Byetta)
- Improving Survival in the Western Tidewater Area
- Painful Diabetic Neuropathy Study
- Reduce and Identify Diabetes (RID) Program
- Wii Study